Hello, I am Meriem Bouslouk-Marx

From the outset, my particular focus at the Federal Health Authority in Germany was on rare diseases. The German Government had introduced incentives for the national Health Technology Assessment (HTA) of rare disease therapies, commonly called orphan drugs. I coordinated the new national HTA procedure of orphan drugs in Germany. Besides medical and statistical expertise, this specific procedure required targeted health policy considerations. The launch of gene therapies in Germany even increased the challenges in this field.

After my French Baccalauréat at the Lycée Descartes in Rabat, Morocco, I graduated with a PhD in Dental Medicine from the Friedrich Schiller University in Jena, Germany. In connection with my postgraduate Master of Science in International Health from the Charité University Hospital in Berlin, I managed Public Health projects in Africa, especially in Tanzania (Amref Health Africa and rural health), Morocco (WHO Country Office), Burundi and Guinea (Health Focus GmbH). From the start at the German Health Authority in 2011, I was entrusted to promote the G-BA’s work outside Germany: In lectures and speeches, within and outside the G BA, I fostered partnerships with European and international organisations. I speak French, Arabic, German and English.